
(the 'Group', the 'Company' or 'CAML')
Initiation of
Details of the Buyback Programme
The purpose of the Buyback Programme is to reduce the share capital of the Company and to return capital to those shareholders wishing to participate in the Buyback Programme.
Purchases pursuant to the Buyback Programme will be conducted in accordance with the general authority to re-purchase up to 18,190,494 Ordinary Shares granted by the Company's shareholders at the 2025 annual general meeting and will be carried out on the
The Company has entered into an agreement with
The Buyback Programme will commence on the date of this announcement and will continue until
Owing to the limited liquidity in the Company's Ordinary Shares, the repurchases of Ordinary Shares relating to the Buyback Programme on any trading day may represent a significant portion of the Company's daily trading volumes. Daily repurchases may exceed 25% of the average daily trading volume specified in the provisions of the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 (each as in force in the
Any purchase of Ordinary Shares pursuant to the Buyback Programme will be announced by the Company by not later than 07.30 on the business day following the calendar day on which the purchase occurred.
Market abuse regulation
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of
For further information contact:
|
Tel: +44 (0) 20 7898 9001 |
|
|
CEO |
|
|
|
CFO |
|
|
|
Investor Relations Manager |
|
Peel Hunt (Nominated Adviser and Joint Broker) |
Tel: +44 (0) 20 7418 8900 |
|
|
|
|
|
|
|
Tel: +44 (0) 20 7236 1010 |
|
|
|
|
BlytheRay (PR Advisers) |
Tel: +44 (0) 20 7138 3204 |
|
|
|
|
Note to editors:
For further information, please visit www.centralasiametals.com and follow CAML on X at @CamlMetals and on LinkedIn at
All references to dollars in this announcement are US dollars unless otherwise stated.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the